Consistent with the loss of MHC-I expression, we also showed that the number of tumor-infiltrating CD8+ cytotoxic T lymphocytes dropped, in parallel with the reduced melanoma MHC-I and melan-A levels. The gene discussed is CD8A; the disease is neoplasm.